APA

Fu K., Corbley M. J., Sun L., Friedman J. E., Shan F., Papadatos J. L., Costa D., Lutterodt F., Sweigard H., Bowes S., Choi M., Boriack-Sjodin P. A., Arduini R. M., Sun D., Newman M. N., Zhang X., Mead J. N., Chuaqui C. E., Cheung H., Zhang X., Cornebise M., Carter M. B., Josiah S., Singh J., Lee W., Gill A. & Ling L. E. (20080421). SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model. : Arteriosclerosis, thrombosis, and vascular biology.

Chicago

Fu Kai, Corbley Michael J, Sun Lihong, Friedman Jessica E, Shan Feng, Papadatos James L, Costa Donald, Lutterodt Frank, Sweigard Harry, Bowes Scott, Choi Michael, Boriack-Sjodin P Ann, Arduini Robert M, Sun Dongyu, Newman Miki N, Zhang Xiamei, Mead Jonathan N, Chuaqui Claudio E, Cheung H-Kam, Zhang Xin, Cornebise Mark, Carter Mary Beth, Josiah Serene, Singh Juswinder, Lee Wen-Cherng, Gill Alan and Ling Leona E. 20080421. SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model. : Arteriosclerosis, thrombosis, and vascular biology.

Harvard

Fu K., Corbley M. J., Sun L., Friedman J. E., Shan F., Papadatos J. L., Costa D., Lutterodt F., Sweigard H., Bowes S., Choi M., Boriack-Sjodin P. A., Arduini R. M., Sun D., Newman M. N., Zhang X., Mead J. N., Chuaqui C. E., Cheung H., Zhang X., Cornebise M., Carter M. B., Josiah S., Singh J., Lee W., Gill A. and Ling L. E. (20080421). SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model. : Arteriosclerosis, thrombosis, and vascular biology.

MLA

Fu Kai, Corbley Michael J, Sun Lihong, Friedman Jessica E, Shan Feng, Papadatos James L, Costa Donald, Lutterodt Frank, Sweigard Harry, Bowes Scott, Choi Michael, Boriack-Sjodin P Ann, Arduini Robert M, Sun Dongyu, Newman Miki N, Zhang Xiamei, Mead Jonathan N, Chuaqui Claudio E, Cheung H-Kam, Zhang Xin, Cornebise Mark, Carter Mary Beth, Josiah Serene, Singh Juswinder, Lee Wen-Cherng, Gill Alan and Ling Leona E. SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model. : Arteriosclerosis, thrombosis, and vascular biology. 20080421.